Expert Opinion on Drug Safety, Volume 23, Issue 1 (2024)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 23, Issue 1 (2024)

See all volumes and issues
Volume 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Drug Safety Evaluation

Review Article
A safety evaluation of ruxolitinib for the treatment of polycythemia vera
Valentina Boldrini, Alessandro M. Vannucchi & Paola Guglielmelli
Pages: 1-7
Published online: 29 Dec 2023
AbstractforA safety evaluation of ruxolitinib for the treatment of polycythemia vera | Full Text | References | PDF (361 KB) | EPUB
  • 260 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future
Davide Fiore Bavaro, Alessandra Belati, Linda Bussini, Valeria Cento, Lucia Diella, Milo Gatti, Annalisa Saracino, Federico Pea, Pierluigi Viale & Michele Bartoletti
Pages: 9-36
Published online: 29 Dec 2023
AbstractforSafety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future | Full Text | References | PDF (2.1 MB) | EPUB
  • 246 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta-analysis

Review Article
Comparative efficacy and safety of different doses of ponatinib versus other tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia: a systematic review and network meta-analysis
Shan Zhang, Hurong Lai, Huijun Chen, Jingyu Wang, Huaijun Tu & Jian Li
Pages: 37-45
Published online: 26 Oct 2023
AbstractforComparative efficacy and safety of different doses of ponatinib versus other tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia: a systematic review and network meta-analysis | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 173 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)
Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat & Angela T.H. Kwan
Pages: 47-55
Published online: 19 Dec 2023
AbstractforThe association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS) | Full Text | References | PDF (3.4 MB) | EPUB
  • 1152 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study
Qingnan Zhao, Yijiong Tan, Qinqin Wu, Xiangqin Xiao, Xinyi Wei, Mengqing Nian, Jie Yao, Nengguang Fan, Ruiping Wang & Guorong Fan
Pages: 57-65
Published online: 10 Nov 2023
AbstractforThe risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study | Full Text | References | PDF (946.5 KB) | EPUB | Supplemental
  • 245 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Priapism associated with anti-seizure medications: a pharmacovigilance study and a review of published cases
Nemanja Z. Petrović, Ana V. Pejčić & Ivan R. Milovanović
Pages: 67-78
Published online: 11 Dec 2023
AbstractforPriapism associated with anti-seizure medications: a pharmacovigilance study and a review of published cases | Full Text | References | PDF (422 KB) | EPUB | Supplemental
  • 221 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Safety and effectiveness of rasagiline in patients with Parkinson’s disease in Japan: a post-marketing surveillance study
Nobutaka Hattori, Mika Kajita, Shinji Fujimoto, Miwa Izutsu & Jovelle Fernandez
Pages: 79-88
Published online: 20 Dec 2023
AbstractforSafety and effectiveness of rasagiline in patients with Parkinson’s disease in Japan: a post-marketing surveillance study | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1748 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors
Hinata Ueda, Katsuya Narumi, Shuho Asano, Yoshitaka Saito, Ayako Furugen & Masaki Kobayashi
Pages: 89-97
Published online: 18 Dec 2023
AbstractforComparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 132 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Safety analysis of antineoplastic drugs for lung cancer: a retrospective analysis based on Shaanxi Province in Western China
Shuang Lei, Ningsheng Wang, Biqi Ren, Shuzhi Lin & Bianling Feng
Pages: 99-105
Published online: 21 Mar 2023
AbstractforSafety analysis of antineoplastic drugs for lung cancer: a retrospective analysis based on Shaanxi Province in Western China | Full Text | References | PDF (236.2 KB) | EPUB | Supplemental
  • 142 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Adverse event profile of CGRP monoclonal antibodies: findings from the FDA adverse event reporting database
Qi Wang, Jingfang Liu, Hao Sun, YongFei Dong, WeiLiang Tan, Zaixiang Tang & YiGuo Jiang
Pages: 107-117
Published online: 18 Sep 2023
AbstractforAdverse event profile of CGRP monoclonal antibodies: findings from the FDA adverse event reporting database | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 2777 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports
Pengjiao An, Xin Liu & Bo Zhang
Pages: 119-128
Published online: 19 Apr 2023
AbstractforSafety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports | Full Text | References | PDF (338 KB) | EPUB
  • 362 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda
Jonathan Kuteesa, Marble Nasasira & Ronald Kiguba
Pages: 129-136
Published online: 08 Aug 2023
AbstractforEpidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda | Full Text | References | PDF (276.7 KB) | EPUB | Supplemental
  • 1162 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Association between methotrexate-induced Stevens-Johnson syndrome/toxic epidermal necrolysis and furosemide: a real-world disproportionality analysis
Shengnan Zhuo, Tu Dong, Zhongsheng Yue, Yating Qian, Xinling Liu & Wei Liu
Pages: 137-144
Published online: 17 Apr 2023
AbstractforAssociation between methotrexate-induced Stevens-Johnson syndrome/toxic epidermal necrolysis and furosemide: a real-world disproportionality analysis | Full Text | References | PDF (713.7 KB) | EPUB | Supplemental
  • 220 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles